$CABA 90 DAYS STOCK PRICE FORECAST

Stock Price

About the Company

Cabaletta Bio is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases. The Cabaletta Approach to selective B cell Ablation (CABA) platform, in combination with Cabaletta's proprietary technology, utilizes Chimeric AutoAntibody Receptor (CAAR) T cells that are designed to selectively bind and eliminate only specific autoantibody-producing B cells while sparing normal antibody-producing B cells, which are essential for human health. The Company's lead product candidate, DSG3-CAART, is being evaluated in the DesCAARTes™ phase 1 clinical trial as a potential treatment for patients with mucosal pemphigus vulgaris, a prototypical B cell-mediated autoimmune disease. The FDA granted Fast Track Designation for DSG3-CAART in May 2020. The Company's lead preclinical product candidate, MuSK-CAART, is in IND-enabling studies and is designed as a potential treatment for patients with MuSK-associated myasthenia gravis.

Exchange

NASDAQ

Website

www.cabalettabio.com

$M

Total Revenue

34

Employees

$289M

Market Capitalization

-6.96

Price/Earning ratio

Similar Companies

Name Ticker Market Capitalization (USD M) Revenue (USD M) Price/Book Price/Earning Net Margin (%)
Charles River Laboratories Int CRL 21297 3273 9.08 53.74 12.10
Exact Sciences Corp. EXAS 13407 1760 4.00 -15.77 -46.50
PRA Health Sciences Inc PRAH 10739 3333 6.88 50.52 6.40
Syneos Health Inc SYNH 10131 4980 3.01 40.54 5.04
Medpace Holdings Inc MEDP 8027 1094 8.45 43.73 16.65
Vir Biotechnology Inc VIR 6064 284 6.86 -55.35 -35.98
Exelixis Inc EXEL 5290 1254 2.47 32.31 13.10
Twist Bioscience Corp TWST 4280 127 7.36 -32.52 -106.59
Allakos Inc ALLK 3929 7.67 -17.95 None
Recursion Pharmaceuticals Inc RXRX 3213 10 5.37 -21.85 None
Sana Biotechnology Inc SANA 3212 3.99 -8.95 None
Instil Bio Inc TIL 2808 0 4.67 -23.66 None
Allogene Therapeutics Inc ALLO 2539 38 2.80 -10.15 -652.24
Lyell Immunopharma Inc LYEL 2282 10 2.32 -11.06 None
Erasca Inc ERAS 1806 3.81 -11.16 None
Verve Therapeutics Inc VERV 1581 4.12 -14.08 None
Constellation Pharmaceuticals CNST 1564 4.32 -11.18 None
Pandion Therapeutics Inc PAND 1501 1069 1.83 -13.34 -10.55
Sorrento Therapeutics Inc SRNE 1485 51 12.12 -4.24 -692.36
Replimune Group Inc REPL 1419 2.85 -14.34 None
Organogenesis Holdings Inc ORGO 1279 446 6.54 19.63 13.94
Alx Oncology Holdings Inc ALXO 1240 1 3.26 -21.24 -401.23
AlloVir Inc ALVR 1104 0 4.34 -12.03 -718.59
National Research Corp NRC 1097 144 12.91 30.14 24.95
Caribou Biosciences Inc CRBU 1081 8 2.68 -17.15 -787.07
Rubius Therapeutics Inc RUBY 1066 4.98 -5.84 None
Castle Biosciences Inc CSTL 1006 86 2.58 -33.81 -34.46
Scholar Rock Holding Corp SRRK 927 18 4.83 -7.55 -672.72
Crinetics Pharmaceuticals Inc CRNX 909 0 6.37 -9.31 -447.78
Nuvalent Inc NUVL 907 3.03 -23.92 None
Design Therapeutics Inc DSGN 870 0 2.25 -31.00 -245.44
Omega Therapeutics Inc OMGA 851 3.85 -14.90 None
Icosavax Inc ICVX 848 7 2.90 -15.99 -723.56
Century Therapeutics Inc IPSC 841 1.98 -10.06 None
RAPT Therapeutics Inc RAPT 837 4 4.72 -13.20 7.14
Tenaya Therapeutics Inc TNYA 814 2.70 -14.38 None
Monte Rosa Therapeutics Inc GLUE 788 2.16 -11.34 None
Tyra Biosciences Inc TYRA 783 2.54 -38.96 None
Precigen Inc PGEN 770 99 6.33 -7.00 -109.91
MeiraGTx Holdings plc MGTX 759 20 4.18 -9.65 -391.81
Kezar Life Sciences Inc KZR 755 6.09 -14.80 None
Sutro Biopharma Inc STRO 731 60 2.65 -4.83 -213.36
Cullinan Oncology Inc CGEM 714 19 1.60 -11.51 -324.14
Y-Mabs Therapeutics Inc YMAB 710 46 3.50 -18.57 -83.20
Ideaya Biosciences Inc IDYA 705 36 2.59 -20.16 -103.19
Imago BioSciences Inc IMGO 701 -9.01 -26.92 None
Janux Therapeutics Inc JANX 633 2 1.71 -30.27 -436.67
Vera Therapeutics Inc VERA 599 7.09 -10.33 None
Talaris Therapeutics Inc TALS 558 2.20 -13.75 None
Immuneering Corp IMRX 530 3 3.34 -18.54 -887.28
Graphite Bio Inc GRPH 514 1.29 -8.53 None
Precision Biosciences Inc DTIL 497 118 5.22 -15.03 -26.91
Vor Biopharma Inc VOR 480 2.08 -6.90 None
Xilio Therapeutics Inc XLO 438 -3.56 -5.73 None
Evelo Biosciences Inc EVLO 420 13.30 -3.44 None
Cortexyme Inc CRTX 417 3.13 -4.73 None
Mirum Pharmaceuticals Inc MIRM 399 16 7.48 -2.25 None
Pyxis Oncology Inc PYXS 389 -5.57 -6.04 None
Werewolf Therapeutics Inc HOWL 370 2.23 -1.95 None
Rallybio Corp RLYB 362 38 1.95 -8.07 -1.07
Cue Biopharma Inc CUE 355 7 5.72 -7.53 -654.54
Sera Prognostics Inc SERA 323 0 2.13 -11.45 None
Acumen Pharmaceuticals Inc ABOS 320 0 1.39 -3.46 -550.91
Aerovate Therapeutics Inc AVTE 313 1.77 -17.41 None
Biomea Fusion Inc BMEA 311 1.63 -10.23 None
MiNK Therapeutics Inc INKT 298 -5.49 -16.64 None
Eliem Therapeutics Inc ELYM 295 1.71 -5.18 None
Cabaletta Bio Inc CABA 289 2.81 -6.96 None
Magenta Therapeutics Inc MGTA 288 1.71 -4.13 None
Applied Therapeutics Inc APLT 285 14 3.44 -2.75 -19.41
Candel Therapeutics Inc CADL 279 0 4.37 -5.72 None
Luna Innovations Inc LUNA 271 106 3.32 -821.00 -0.24
Oyster Point Pharma Inc OYST 267 18 1.95 -3.29 -450.47
Surface Oncology Inc SURF 253 90 1.98 10.05 14.33
Compass Therapeutics Inc CMPX 247 8.47 -3.04 None
Black Diamond Therapeutics Inc BDTX 224 1.03 -1.83 None
Gemini Therapeutics Inc GMTX 211 1088 0.23 1.74 11.24
Sensei Biotherapeutics Inc SNSE 209 1.33 -6.36 None
Impel NeuroPharma Inc. IMPL 204 0 2.70 -3.13 None
Pieris Pharmaceuticals Inc PIRS 199 25 4.35 -3.88 -203.63
INmune Bio Inc INMB 181 0 2.44 -7.68 None
Alzamend Neuro Inc ALZN 177 11.28 -29.00 None
Tscan Therapeutics Inc TCRX 168 8 0.96 -3.94 -522.54
Nextcure Inc NXTC 168 22 0.67 -2.44 -163.57
AquaBounty Technologies Inc AQB 162 1 0.83 -6.76 None
Reneo Pharmaceuticals Inc RPHM 151 0.99 -4.35 None
Elevation Oncology Inc ELEV 147 0.99 -4.73 None
IN8bio Inc INAB 105 2.40 -10.19 None
Unity Biotechnology Inc UBX 104 1 1.89 -1.50 None
Axcella Health Inc AXLA 104 2700 3.00 -1.69 -10.84
HCW Biologics Inc HCWB 101 4 1.85 -14.74 -165.52
BioVie Inc BIVI 98 7.14 -0.79 None
Hookipa Pharma Inc HOOK 97 20 0.75 -1.48 -339.34
Statera BioPharma Inc STAB 86 0 None -2.99 None
Cyclerion Therapeutics Inc CYCN 73 4 1.52 -1.21 None
RenovoRx Inc RNXT 61 3.44 -12.54 None
Synaptogenix Inc SNPX 53 1.67 -3.51 None
NanoViricides Inc NNVC 50 1.85 -5.55 None
Monopar Therapeutics Inc MNPR 48 2.39 -5.69 None
Acurx Pharmaceuticals Inc ACXP 42 3.01 -3.80 None
Eloxx Pharmaceuticals Inc ELOX 42 0 1.91 -0.73 -14.14
Exicure Inc XCUR 41 4 1.12 -0.87 -148.49
Vaccinex Inc VCNX 41 1 3.92 -1.70 -48.71
Scopus Biopharma Inc SCPS 41 234 22.80 -1.65 80.93
TransCode Therapeutics Inc RNAZ 35 1.53 -8.03 None
Rezolute Inc RZLT 35 3.16 -1.46 None
Unicycive Therapeutics Inc UNCY 30 113 1.57 -3.70 7.94
Cyclo Therapeutics Inc CYTH 30 1 5.48 -1.31 -989.80
Cytocom Inc CBLI 30 0 3.88 -12.72 -912.16
CohBar Inc CWBR 29 2.96 -1.69 None
AgeX Therapeutics Inc AGE 25 2 -2.54 -2.75 -502.97
Aridis Pharmaceuticals Inc ARDS 24 1 -7.13 -0.55 -851.00
Kiromic BioPharma Inc KRBP 17 7.37 -1.17 None
Tenax Therapeutics Inc TENX 17 0 4.07 -0.55 -840.64
Geovax Labs Inc GOVX 16 1 1.29 -10.89 -558.09
Xenetic Biosciences Inc XBIO 11 1 0.84 -2.26 -510.87
BioRestorative Therapies Inc BRTX 6 0 -4.01 -0.10 None
Neurotrope Inc NTRP 5 29 0.08 0.76 23.48

Wall Street Analysts Predict a 52% Upside in Cabaletta Bio, Inc. (CABA): Here's What You Should Know

27d ago, source: Business Insider

Disclaimer | Accessibility Statement | Commerce Policy | Made In NYC | Stock quotes by finanzen.net Cabaletta Bio, Inc. (CABA) closed the last trading session at $14, gaining 24% over the past ...

Cabaletta Bio to Participate in Upcoming Investor Conferences in November

23d ago, source: Yahoo Finance

PHILADELPHIA, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies ...

CABA

11d ago, source: Seeking Alpha

Combination chart with 2 data series. Chart represents Cabaletta Bio, Inc. price and volume over 1Y period View as data table, Cabaletta Bio, Inc. price and volume The chart has 1 X axis ...

Cabaletta Bio Inc Ordinary Shares CABA

7d ago, source: Morningstar%2c Inc.

There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible ...

Cabaletta Bio to Participate in Upcoming Investor Conferences in November

23d ago, source: Middle East North Africa Financial Network

(MENAFN- GlobeNewsWire - Nasdaq) PHILADELPHIA, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development ...

Wall Street Analysts Predict a 52% Upside in Cabaletta Bio, Inc. (CABA): Here's What You Should Know

1mon ago, source: Nasdaq

Cabaletta Bio, Inc. (CABA) closed the last trading session at $14, gaining 24% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by ...

Cabaletta Bio Inc (CABA)

24d ago, source: Investing.com

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Cabaletta Bio Inc (CABA)

16d ago, source: Investing.com

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and ...

Wall Street Analysts Predict a 52% Upside in Cabaletta Bio, Inc. (CABA): Here's What You Should Know

1mon ago, source: Yahoo News

Cabaletta Bio, Inc. (CABA) closed the last trading session at $14, gaining 24% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall ...

Cabaletta Bio to Participate in Upcoming Investor Conferences in November

23d ago, source: Yahoo Finance

PHILADELPHIA, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for ...

Cabaletta Bio Inc (CABA)

28d ago, source: Investing

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Your Portfolio